1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NW Natural Holdings reported a second-quarter 2025 net loss of $2.5 million, or $0.06 per share, compared with a $2.8 million loss, or $0.07 per share, a year earlier, and adjusted net income of $0.3 million, or $0.01 per share. For the first six months of 2025, net income rose to $85.4 million, or $2.11 per share, from $61.0 million, or $1.60 per share, and the company reaffirmed 2025 adjusted EPS guidance of $2.75 to $2.95 while updating GAAP EPS guidance to $2.60 to $2.80. The results point to improving profitability for shareholders, although the company still recorded a GAAP loss for the quarter.
Second-quarter net loss of $2.5 million ($0.06 per share) vs. $2.8 million ($0.07 per share) in Q2 2024; adjusted EPS of $0.01
First-half net income of $85.4 million ($2.11 per share) vs. $61.0 million ($1.60 per share) in the first half of 2024
2025 adjusted EPS guidance of $2.75 to $2.95 reaffirmed; GAAP EPS guidance updated to $2.60 to $2.80
Quarterly dividend of $0.49 per share declared, payable Aug. 15, 2025 to holders of record on July 31, 2025
CorVel reported results for the quarter ended June 30, 2025, with revenue of $235 million, up from $212 million a year earlier, and diluted earnings per share of $0.52, up from $0.42. The company also said it completed, in July, the acquisition of assets and key talent from a privately held technology firm to strengthen its CERIS group health division; the filing does not state the purchase price.
Revenue rose 11% to $235 million, versus $212 million in the June quarter of 2024.
Diluted EPS rose 24% to $0.52 from $0.42, adjusted for the three-for-one stock split paid December 24, 2024.
Gross profit rose 18% to $56.8 million, at a 24% gross margin, versus $48.2 million a year earlier.
Cash was $202 million with no borrowings at quarter end; the company repurchased $9.6 million of common stock during the quarter.
Standex reported fiscal fourth-quarter 2025 results for the period ended June 30, 2025. Sales rose 23.2% year over year to $222.0 million, and adjusted EPS rose 20.6% to $2.28, while GAAP diluted EPS fell 25.9% to $1.23 from $1.66, reflecting higher amortization and acquisition-related costs tied to recent acquisitions. The company expects fiscal 2026 revenue to grow by more than $100 million.
Q4 FY25 net sales were $222.0 million, up from $180.2 million a year earlier, with the Amran/Narayan Group acquisition a major contributor.
GAAP diluted EPS was $1.23 versus $1.66 a year earlier; adjusted diluted EPS was $2.28 versus $1.89.
Adjusted operating margin was 20.6%, up 350 basis points year over year; GAAP operating margin was 15.6%.
For fiscal 2026, the company expects revenue to grow by over $100 million and fast growth market sales to exceed $265 million.
Archrock reported second-quarter 2025 revenue of $383.2 million, up from $270.5 million a year earlier, and net income of $63.4 million, or $0.36 per share, compared with $34.4 million and $0.22 in the second quarter of 2024. The company also raised its full-year 2025 adjusted EBITDA guidance, citing continued outperformance, which signals higher expected earnings for shareholders.
Q2 2025 adjusted EBITDA was $212.7 million, compared with $129.7 million in Q2 2024.
Q2 2025 adjusted EPS was $0.39, compared with $0.23 in Q2 2024.
The quarterly dividend was $0.21 per share, about 27% higher than Q2 2024, with dividend coverage of 3.4x.
Archrock repurchased 1,226,954 shares for about $28.8 million in Q2 and had $58.9 million of repurchase capacity left as of June 30, 2025.
JBT Marel reported second quarter 2025 revenue of $935 million, up from $402 million a year earlier, after the Marel transaction closed at the beginning of 2025. Income from continuing operations fell to $3 million, or $0.07 diluted EPS, from $31 million a year earlier, and the company re-established full year 2025 guidance, including revenue of $3,675 million to $3,725 million and adjusted EPS of $5.45 to $6.15.
Q2 2025 revenue was $935 million versus $402 million in Q2 2024; adjusted EBITDA was $156 million versus $64 million.
Income from continuing operations was $3 million ($0.07 diluted EPS) versus $31 million ($0.95 diluted EPS) a year earlier; adjusted EPS was $1.49.
Full year 2025 guidance: revenue $3,675 million to $3,725 million, GAAP EPS ($1.90) to ($1.20), adjusted EPS $5.45 to $6.15.
The filing cites an $11 million loss on investment from a joint-venture impairment and $20 million in M&A related costs in the quarter.
Cabot reported fiscal third-quarter 2025 results with diluted EPS of $1.86 and adjusted EPS of $1.90, both below the prior-year quarter, while net sales fell to $923 million from $1.016 billion. The company reaffirmed its fiscal 2025 adjusted EPS guidance of $7.15 to $7.50 but said that at current demand levels it expects to land in the middle to lower end of that range.
Diluted EPS was $1.86 versus $1.94 a year earlier; adjusted EPS was $1.90 versus $1.92, a 1% decrease
Net sales and other operating revenues were $923 million versus $1,016 million; net income attributable to Cabot was $101 million versus $109 million
Reinforcement Materials segment EBIT fell 6% to $128 million; Performance Chemicals segment EBIT rose 4% to $57 million
Fiscal 2025 adjusted EPS guidance of $7.15 to $7.50 was reaffirmed; management cited tariff uncertainty and weaker demand
Kyndryl reported first-quarter fiscal 2026 results for the quarter ended June 30, 2025, with revenue of $3.74 billion, up slightly on a reported basis and down 2.6% in constant currency. Net income rose to $56 million, or $0.23 per diluted share, from $11 million, or $0.05, a year earlier, and the company reaffirmed its fiscal 2026 outlook for revenue, earnings and free cash flow.
Revenue of $3.74 billion was up slightly year-over-year as reported and down 2.6% in constant currency
Net income was $56 million ($0.23 per diluted share) versus $11 million ($0.05) a year earlier; adjusted EPS was $0.37 versus $0.13
Free cash flow was a use of $222 million in the quarter, which the company attributed to typical seasonal outflows
Fiscal 2026 outlook reaffirmed, including adjusted pretax income of at least $725 million and free cash flow of approximately $550 million
MSA Safety reported second quarter 2025 results on August 4, 2025. Net sales rose 3% to $474 million but were flat on an organic basis, while GAAP net income fell 13% to $63 million and diluted EPS fell to $1.59 from $1.83. The company maintained its low-single-digit full-year organic sales growth outlook for 2025, citing macroeconomic risk and the timing of NFPA approval for its next-generation SCBA.
Q2 net sales $474 million, up 3% GAAP and flat organic, versus $462 million a year earlier
GAAP operating income $86 million (18.1% of sales) versus $100 million; GAAP diluted EPS $1.59 versus $1.83
Adjusted diluted EPS $1.93 versus $2.01; 2025 organic sales growth outlook maintained at low single digits
Acquired M&C TechGroup in a transaction valued at $188 million, net of cash acquired
Atlas Energy Solutions reported second-quarter 2025 revenue of $288.7 million, down 3.0% from the first quarter, and a net loss of $5.6 million, compared with net income of $1.2 million in the prior quarter. The company expects a modest decline in both consolidated revenue and Adjusted EBITDA in the third quarter, which weighs on the outlook for shareholders, though the quarterly dividend of $0.25 per share was maintained.
Q2 2025 revenue was $288.7 million, versus $297.6 million in Q1 2025 and $287.5 million in Q2 2024.
Net loss was $5.6 million, or $(0.04) per share, compared with net income of $1.2 million in Q1 2025.
Adjusted EBITDA was $70.5 million, down from $74.3 million in Q1 2025.
Third-quarter guidance calls for a modest decline in consolidated revenue and Adjusted EBITDA, with higher proppant volume offset by lower average prices and short-fall payments.
Vornado Realty Trust reported second-quarter 2025 results on August 4, 2025. GAAP net income attributable to common shareholders rose to $743.8 million, or $3.70 per diluted share, from $35.3 million, or $0.18, a year earlier, mainly due to an $803.2 million gain tied to the 770 Broadway master lease with NYU. Revenues fell to $441.4 million from $450.3 million, and FFO as adjusted was $0.56 per diluted share versus $0.57 a year earlier, so the one-time gain drives the headline profit increase while core operating measures were flat to lower.
Net income attributable to common shareholders: $743.8 million, or $3.70 per diluted share, for the quarter ended June 30, 2025, versus $35.3 million, or $0.18, a year earlier
The increase is primarily due to the $803.2 million gain from the 770 Broadway master lease with NYU, completed May 5, 2025
FFO as adjusted was $113.3 million, or $0.56 per diluted share, versus $112.8 million, or $0.57, in Q2 2024; revenues were $441.4 million versus $450.3 million
Q2 earnings conference call scheduled for Tuesday, August 5, 2025 at 10:00 a.m. ET
Tidewater reported second-quarter 2025 revenue of $341.4 million and net income of $72.9 million, or $1.46 per diluted share, compared with $50.4 million, or $0.94 per share, a year earlier. The net income includes a one-time, non-cash $27.0 million increase from reversing a valuation allowance on U.S. net operating losses, and the company reiterated its 2025 revenue and gross margin guidance. The Board also approved a share repurchase program of up to $500.0 million, which the company may modify, suspend or discontinue at any time.
Q2 2025 revenue of $341.4 million, up 0.6% from $339.2 million in Q2 2024.
Net income attributable to Tidewater of $72.9 million ($1.46 diluted per share), versus $50.4 million ($0.94) a year earlier, including a one-time, non-cash $27.0 million benefit.
Board authorized a share repurchase program of up to $500.0 million; the company is not obligated to buy any specific number of shares.
2025 revenue guidance of $1.32 billion to $1.38 billion and gross margin guidance of 48% to 50% were reiterated.
Centerspace reported a second-quarter 2025 net loss of $0.87 per diluted share, compared with $0.19 a year earlier, after a $14.5 million real estate impairment. Revenue rose 5.4% to $68.5 million and Core FFO per diluted share edged up to $1.28 from $1.27, but the company narrowed and lowered its 2025 FFO per diluted share outlook to $4.70 to $4.83 from $4.73 to $4.97. The Board also authorized a share repurchase program of up to $100 million through July 31, 2026.
Q2 2025 net loss was $0.87 per diluted share versus $0.19 in Q2 2024; six-month net loss was $1.09 versus $0.56.
Core FFO was $1.28 per diluted share versus $1.27; same-store NOI rose 2.9% year over year.
2025 FFO per diluted share outlook is $4.70 to $4.83, down from $4.73 to $4.97; Core FFO outlook is $4.88 to $5.00, down from $4.86 to $5.10.
Repurchase program of up to $100 million of common shares was effective July 31, 2025, with no obligation to buy any specific number of shares.
HealthStream reported second-quarter 2025 revenue of $74.4 million, up 4.0% and a company record, with net income of $5.4 million, up 29.3%, and diluted EPS of $0.18 versus $0.14 a year earlier. The company raised its 2025 net income guidance to $19.5 million-$22.4 million from $18.6 million-$21.0 million, and the board declared a $0.031 quarterly dividend.
Q2 2025 revenue was $74.4 million, up from $71.6 million in Q2 2024, a company record for quarterly revenue.
Q2 2025 net income was $5.4 million and diluted EPS was $0.18, compared with $4.2 million and $0.14 in Q2 2024.
Full-year 2025 net income guidance was raised to $19.5 million-$22.4 million from $18.6 million-$21.0 million; revenue guidance is $297.5 million-$303.5 million.
The board declared a $0.031 per share dividend payable August 29, 2025, to holders of record on August 18, 2025; the $25.0 million buyback program was completed in July.
New Jersey Resources reported a fiscal third-quarter GAAP net loss of $15.1 million, or $(0.15) per share, wider than the $11.6 million loss a year earlier. Its non-GAAP net financial earnings (NFE) turned positive at $6.2 million, or $0.06 per share, and the company raised the low end of its fiscal 2025 NFE per share guidance by $0.05, to $3.20 to $3.30.
Q3 GAAP net loss of $15.1 million, or $(0.15) per share, versus a net loss of $11.6 million, or $(0.12) per share, in Q3 fiscal 2024
Q3 net financial earnings of $6.2 million, or $0.06 per share, versus a net financial loss of $8.9 million, or $(0.09) per share, a year earlier
Fiscal 2025 NFE per share guidance low end raised $0.05, from $3.15 to $3.30 to $3.20 to $3.30
Q3 total operating revenues of $298.9 million, up from $275.6 million; nine-month net income of $320.6 million, or $3.20 per share
Ingevity reported second quarter 2025 net sales of $365.1 million, down 7%, and a net loss of $146.5 million, or $4.02 per diluted share, which included a $183.8 million non-cash goodwill impairment tied to the Advanced Polymer Technologies segment. Adjusted earnings rose 39% to $51.1 million, and the company raised the low end of its full-year adjusted EBITDA guidance to a range of $390 million to $415 million while maintaining its sales guidance of $1.25 billion to $1.40 billion.
Q2 net sales were $365.1 million, down 7%, mainly due to lower Performance Chemicals sales
Net loss of $146.5 million and diluted loss of $4.02 per share, including a $183.8 million goodwill impairment
Adjusted earnings rose 39% to $51.1 million; diluted adjusted EPS was $1.39, up 38%
Full-year 2025 adjusted EBITDA guidance is $390 million to $415 million; sales guidance remains $1.25 billion to $1.40 billion
Encompass Health reported second-quarter 2025 net operating revenue of $1,457.7 million, up 12.0% from $1,301.2 million a year earlier, and diluted earnings per share from continuing operations of $1.40, up from $1.13. The company raised its full-year 2025 guidance for net operating revenue, adjusted EBITDA and adjusted earnings per share, which gives shareholders a higher outlook for the year.
Q2 2025 net operating revenue was $1,457.7 million, up 12.0%; diluted EPS from continuing operations was $1.40 versus $1.13.
Adjusted EPS was $1.40 versus $1.11 a year earlier; adjusted EBITDA was $318.6 million, up 17.2%.
Full-year 2025 adjusted EPS guidance rose to $5.12 to $5.34 from $4.85 to $5.10; net operating revenue guidance rose to $5,880 to $5,980 million.
Management will discuss results on an earnings call at 10:00 a.m. Eastern Time on August 5, 2025.
ONEOK reported second quarter 2025 net income attributable to ONEOK of $841 million, up from $780 million a year earlier, and diluted earnings of $1.34 per share, compared with $1.33. The company affirmed its full-year 2025 financial guidance ranges, and results were driven mainly by the EnLink and Medallion acquisitions. Shareholders get a higher quarterly profit, but the quarter included $22 million of pretax transaction costs, mostly tied to the EnLink acquisition.
Net income attributable to ONEOK was $841 million for the quarter ended June 30, 2025, versus $780 million in the same period of 2024.
Diluted earnings per share were $1.34, versus $1.33 a year earlier.
Adjusted EBITDA was $1.98 billion, versus $1.62 billion a year earlier; the figure includes $21 million of transaction costs.
ONEOK affirmed its full-year 2025 financial guidance ranges and will hold an earnings conference call on Aug. 5, 2025, at 11 a.m. Eastern.
Axon reported second-quarter 2025 revenue of $669 million, up 33% year over year, and raised its full-year 2025 revenue outlook to $2.65 billion to $2.73 billion from $2.60 billion to $2.70 billion. Net income was $36 million, but the company posted a $1 million operating loss driven by $139 million of stock-based compensation expense, and total gross margin fell 40 basis points year over year to 60.4%. For shareholders, the higher revenue and raised guidance are the main headline measures, while stock-based compensation weighed on reported operating results.
Q2 2025 revenue of $669 million rose 33% year over year; Software & Services revenue rose 39% to $292 million.
Full-year 2025 revenue outlook raised to $2.65 billion to $2.73 billion, from $2.60 billion to $2.70 billion previously.
Full-year 2025 Adjusted EBITDA outlook raised to $665 million to $685 million, from $650 million to $675 million previously.
Q2 net income was $36 million, or $0.44 per diluted share; operating loss of $1 million included $139 million of stock-based compensation expense.
Equity Residential (NYSE: EQR) reported second-quarter 2025 diluted EPS of $0.50, up from $0.47, and FFO of $0.98 per share, up from $0.94. It raised the midpoints of full-year FFO and Normalized FFO guidance but lowered full-year EPS guidance to $2.96 to $3.02 from $3.00 to $3.10. The filing names Equity Residential, not VIVMARK RESIDENTIAL as stated in the request.
Q2 2025 diluted EPS $0.50 vs. $0.47; FFO $0.98 vs. $0.94; Normalized FFO $0.99 vs. $0.97 per share
Six-month diluted EPS of $1.18 vs. $1.24 a year earlier, down 4.8%
Full-year 2025 FFO guidance raised to $4.03-$4.09 from $3.87-$3.97; EPS guidance cut to $2.96-$3.02 from $3.00-$3.10
Q2 same store revenues up 2.7% and same store NOI up 2.3% vs. Q2 2024; eight Atlanta properties acquired for approximately $533.8 million
Boise Cascade reported second quarter 2025 net income of $62.0 million, or $1.64 per diluted share, down from $112.3 million, or $2.84 per share, a year earlier. Sales fell 3% to $1.74 billion, and adjusted EBITDA fell 34% to $119.0 million. Lower engineered wood and plywood prices and downtime for the Oakdale, Louisiana mill modernization weighed on the Wood Products segment, which lost most of its income.
Net income $62.0 million ($1.64 per diluted share) vs. $112.3 million ($2.84) in Q2 2024
Sales $1.74 billion, down 3% from $1.80 billion; Wood Products segment income fell 81% to $14.0 million
Board declared a quarterly dividend of $0.22 per share on July 31, 2025, payable September 17, 2025
Allison Transmission reported second-quarter 2025 net sales of $814 million, essentially flat from $816 million a year earlier, while net income rose 4% to $195 million. The company also revised its full-year 2025 guidance, citing current end-market conditions, acquisition-related expenses and expected favorable cash income tax impacts from the One Big Beautiful Bill Act. Shareholders also get a view of the pending $2.7 billion acquisition of Dana's Off-Highway business, which is expected to close in late Q4 2025.
Q2 2025 diluted EPS was $2.29, up from $2.13 in Q2 2024; net income was $195 million, up from $187 million.
Q2 Adjusted EBITDA was $313 million, up from $301 million, and Adjusted EBITDA margin was 38.5%.
Revised 2025 guidance: net sales $3,075 to $3,175 million, net income $640 to $680 million, Adjusted EBITDA $1,130 to $1,180 million.
Pending Dana Off-Highway acquisition for approximately $2.7 billion, expected to close late in Q4 2025; Q2 acquisition-related expenses were $15 million.
AECOM reported fiscal third-quarter 2025 results for the quarter ended June 30, 2025, with revenue of $4.18 billion, up 0.7%, and net service revenue of $1.94 billion, up 6%. The company raised its fiscal 2025 guidance for adjusted EBITDA, adjusted EPS, and margins, which points to higher expected earnings for shareholders.
Adjusted EPS was $1.34, up 16%; diluted EPS from continuing operations was $1.31, up 38%
Net income attributable to AECOM was $131 million, down 2.5%, including a $43.9 million loss from discontinued operations
Fiscal 2025 adjusted EPS guidance raised to $5.20 to $5.30; adjusted EBITDA guidance set at $1,190 million to $1,210 million
Free cash flow was $262 million in the quarter; year-to-date free cash flow rose 27% to $551 million
Addus HomeCare reported second-quarter 2025 net service revenues of $349.4 million, up 21.8% from a year earlier, and net income of $1.20 per diluted share compared with $1.10. The company also completed its $21.3 million acquisition of Helping Hands Home Care on August 1, 2025, adding three locations in western Pennsylvania. The release does not include updated financial guidance figures.
Net service revenues were $349.4 million, up 21.8% from $286.9 million in Q2 2024.
Net income was $22.1 million, or $1.20 per diluted share, compared with $18.1 million, or $1.10, a year earlier.
Adjusted EBITDA rose 24.5% to $43.9 million; cash flow from operations was $22.5 million.
Helping Hands was acquired for $21.3 million on August 1, 2025, with annualized revenues of approximately $16.7 million.
Hims & Hers reported second-quarter 2025 revenue of $544.8 million, up 73% from a year earlier, and net income of $42.5 million, compared with $13.3 million in the second quarter of 2024. The company affirmed its full-year 2025 revenue and Adjusted EBITDA guidance and gave third-quarter outlook, but free cash flow was negative $69.4 million and gross margin fell to 76% from 81%.
Q2 2025 revenue was $544.8 million, up 73% from $315.6 million; subscribers reached 2,439 thousand, up 31%
Net income was $42.5 million and Adjusted EBITDA was $82.2 million, versus $13.3 million and $39.3 million a year earlier
Free cash flow was negative $69.4 million, compared with positive $47.6 million in Q2 2024
Full-year 2025 guidance affirmed: revenue of $2.3 billion to $2.4 billion and Adjusted EBITDA of $295 million to $335 million; Q3 revenue guidance is $570 million to $590 million
Ichor Holdings reported second quarter 2025 revenue of $240.3 million, up from $203.2 million a year earlier but down from $244.5 million in the first quarter. The company posted a GAAP net loss of $9.4 million, wider than the $5.1 million loss a year earlier, and gave third quarter revenue guidance of $225 million to $245 million. For shareholders, sales grew year over year while GAAP losses widened and cash fell.
Q2 2025 revenue of $240.3 million, compared with $203.2 million in Q2 2024 and $244.5 million in Q1 2025.
GAAP net loss of $9.4 million, or $(0.28) per diluted share, versus $(0.15) in Q2 2024; non-GAAP diluted EPS was $0.03 versus $0.05.
Q3 2025 outlook: revenue of $225 million to $245 million and GAAP diluted EPS of $(0.12) to $0.00.
Cash and cash equivalents were $92.2 million at June 27, 2025, down $17.1 million from the prior quarter.
Palomar Holdings reported second quarter 2025 net income of $46.5 million, or $1.68 per diluted share, up from $25.7 million, or $1.00 per share, a year earlier. It also raised its full-year 2025 adjusted net income outlook to $198 million to $208 million and approved a share repurchase program of up to $150 million through July 31, 2027.
Q2 2025 gross written premiums rose 28.8% to $496.3 million; adjusted net income rose 51.8% to $48.5 million ($1.76 per diluted share).
Combined ratio improved to 78.8% from 79.1%; adjusted return on equity was 23.7%, down from 24.7% a year earlier.
Full-year 2025 adjusted net income outlook raised to $198 million to $208 million from $195 million to $205 million.
Board approved a repurchase program of up to $150 million of common stock, effective July 31, 2025, running through July 31, 2027.
Diamondback Energy reported second quarter 2025 net income attributable to the company of $699 million, or $2.38 per diluted share, down from $837 million, or $4.66 per share, a year earlier, even though total revenues rose to $3.678 billion from $2.483 billion. The company raised its full-year oil production range to 485 - 492 MBO/d and lowered its 2025 cash capital expenditure forecast to $3.4 - $3.6 billion, and its board raised the share repurchase authorization by $2.0 billion to $8.0 billion.
Q2 2025 net income attributable to Diamondback was $699 million, or $2.38 per diluted share, versus $837 million, or $4.66 per share, in Q2 2024; adjusted net income was $785 million, or $2.67 per diluted share.
Total revenues were $3.678 billion, compared with $2.483 billion in Q2 2024.
2025 cash capital expenditure guidance was lowered to $3.4 - $3.6 billion, and 2025 oil production guidance was narrowed to 485 - 492 MBO/d.
The board approved a $2.0 billion increase in the share repurchase authorization to $8.0 billion on July 31, 2025, with about $3.5 billion remaining; the Q2 2025 base dividend is $1.00 per share, payable August 21, 2025.
ZoomInfo reported second-quarter 2025 GAAP revenue of $306.7 million, up 5% year over year, and swung to GAAP net income of $24.0 million from a net loss a year earlier. The company raised its full-year 2025 GAAP revenue and adjusted EPS guidance and named interim CFO Graham O'Brien as permanent CFO effective August 1, 2025. Cash flow from operations fell 14% year over year, which shareholders may watch closely.
Q2 2025 GAAP revenue $306.7 million, up 5% year over year; GAAP net income $24.0 million, or $0.07 per diluted share, versus a net loss of $24.4 million in Q2 2024
FY 2025 GAAP revenue guidance raised to $1.215 billion to $1.225 billion from $1.195 billion to $1.205 billion; adjusted EPS guidance raised to $0.99 to $1.01 from $0.96 to $0.98
Michael Graham O'Brien named permanent CFO effective August 1, 2025, with a $470,000 base salary and a bonus target of 60% of base salary
Q2 cash flow from operations $108.9 million, down 14% year over year; unlevered free cash flow $99.9 million, down 17%
Marriott Vacations Worldwide reported second-quarter 2025 results on August 4, 2025. Net income attributable to common stockholders rose to $69 million from $37 million a year earlier, and total revenues increased 9% to $1.2 billion, while the company reiterated its full-year 2025 outlook. Contract sales slipped 1% to $445 million, and restructuring charges rose to $34 million from $1 million.
Diluted EPS was $1.77 versus $0.98 a year earlier; adjusted diluted EPS was $1.96 versus $1.10.
Adjusted EBITDA was $203 million, up 29% from $158 million.
Full-year 2025 guidance was unchanged, including adjusted EBITDA of $750 million to $780 million.
Vacation Ownership segment Adjusted EBITDA rose 28% to $231 million, while Exchange & Third-Party Management fell 7% to $23 million.
IAC reported second-quarter 2025 revenue of $586.9 million, down 7% from $634.4 million a year earlier, while operating income was $0.6 million compared with a $21.5 million loss. Net earnings of $211.5 million and diluted earnings of $2.57 per share were driven largely by a $307.4 million unrealized gain on its MGM Resorts stake, so shareholders should weigh the falling sales against a profit figure that depends heavily on MGM's share price.
Revenue was $586.9 million, down 7%, with Search revenue down 39% to $61.7 million
Operating income was $0.6 million versus a $21.5 million loss in Q2 2024; Adjusted EBITDA rose 15% to $51.4 million
Diluted earnings per share were $2.57 versus a loss of $1.71, largely reflecting the $307.4 million unrealized MGM gain
Full-year 2025 guidance: operating income of $82-$140 million and Adjusted EBITDA of $247-$285 million
Sabra Health Care REIT reported second-quarter 2025 net income of $0.27 per diluted share, up from $0.10 a year earlier, on total revenues of $189.2 million versus $176.1 million. It also issued 2025 guidance ranges, including net income of $0.77 to $0.79 per share and normalized FFO of $1.45 to $1.47 per share. The filing does not state the prior guidance, so the direction of the update cannot be determined from it.
Q2 2025 net income was $0.27 per diluted share versus $0.10 in Q2 2024; total revenues were $189.2 million versus $176.1 million.
Normalized FFO was $0.37 per diluted share versus $0.35; normalized AFFO was $0.38 versus $0.36.
2025 guidance: net income $0.77 to $0.79 per share; normalized FFO $1.45 to $1.47 per share.
Board declared a quarterly dividend of $0.30 per share on August 4, 2025, payable August 29, 2025 to holders of record on August 15, 2025.
Trex reported second-quarter 2025 net sales of $388 million, up 3% from $376 million a year earlier, but net income fell to $76 million, or $0.71 per diluted share, from $87 million, or $0.80. The company reaffirmed its full-year 2025 guidance of 5% to 7% revenue growth and adjusted EBITDA margin above 31%, and expects third-quarter sales of $295 million to $305 million, which matters to shareholders because profit declined while sales grew.
Q2 gross margin was 40.8%, down from 44.7% a year earlier, which the company attributed to its revised inventory strategy and one-time costs.
Adjusted diluted EPS was $0.73 for the quarter; first-half net income was $136 million, down 23% from $176 million.
Third-quarter 2025 net sales are expected to range from $295 million to $305 million.
Full-year 2025 guidance was reaffirmed at 5% to 7% revenue growth and adjusted EBITDA margin above 31%.
Lattice Semiconductor reported second-quarter 2025 results for the period ended June 28, 2025, with revenue of $124.0 million, up 3.2% from the first quarter and down 0.1% from a year earlier. GAAP net income fell to $2.9 million, or $0.02 per diluted share, from $5.0 million in the first quarter, while non-GAAP diluted earnings per share rose to $0.24 from $0.22. The company also gave third-quarter 2025 revenue guidance of $128 million to $138 million.
Q2 2025 revenue was $124.0 million, up 3.2% from Q1 2025 and down 0.1% from Q2 2024.
GAAP net income was $2.9 million, or $0.02 per diluted share, compared with $5.0 million in Q1 2025 and $22.6 million in Q2 2024.
Non-GAAP diluted earnings per share were $0.24, compared with $0.22 in Q1 2025 and $0.23 in Q2 2024.
Q3 2025 outlook: revenue of $128 million to $138 million and non-GAAP net income of $0.26 to $0.30 per share.
Allegiant reported second-quarter 2025 total operating revenue of $689.4 million, up 3.5% from a year earlier, but a GAAP net loss of $65.2 million, or $3.62 per diluted share, compared with earnings of $0.75 per share in the prior-year quarter. The loss reflects $103.3 million in net Sunseeker Resort special charges tied to the pending $200 million sale of the resort, and adjusted diluted EPS fell 30.5% to $1.23. The company also guided to an adjusted airline-only loss of $1.25 to $2.25 per share for the third quarter.
Q2 2025 GAAP diluted loss per share of $3.62, versus $0.75 earnings per share in Q2 2024
Q2 2025 adjusted diluted EPS of $1.23, down 30.5% from $1.77; adjusted airline-only operating margin of 8.6% versus 10.3%
Third-quarter 2025 guidance: adjusted airline-only EPS of ($1.25) to ($2.25); full-year adjusted airline-only EPS guided above $3.25
Sunseeker Resort sale for $200 million, subject to adjustments, expected to close in the third quarter
Dorman Products reported second-quarter 2025 net sales of $541.0 million, up 7.6% from a year earlier, and diluted EPS of $1.91, up 25%. The company raised its full-year 2025 guidance for net sales growth and diluted EPS, which is a positive signal for shareholders because both headline measures improved and the outlook was lifted.
Net sales were $541.0 million, up 7.6% from $503.0 million in the second quarter of 2024.
Diluted EPS was $1.91 versus $1.53; adjusted diluted EPS was $2.06 versus $1.67.
2025 net sales growth guidance rose to 7% to 9% from 3% to 5%; diluted EPS guidance rose to $8.05 to $8.35 from $7.00 to $7.30.
Management will hold a conference call and webcast on August 5, 2025, at 8:00 a.m. Eastern time.
MercadoLibre reported second-quarter 2025 results, with net revenues and financial income up 34% year over year to $6,790 million. Net income of $523 million was down slightly year over year, and operating margin contracted as the company invested in free shipping and marketing, so shareholders get a mixed picture of growth alongside lower profitability.
Net revenues and financial income of $6,790 million, up 34% year over year (53% on an FX-neutral basis)
Net income of $523 million, a 7.7% margin, down slightly year over year on $117 million of FX losses and a higher tax rate
Income from operations rose 14% year over year to $825 million, but the operating margin of 12.2% contracted by 210 basis points
S&P upgraded the company to investment grade (BBB-) in July; Ariel Szarfsztejn becomes CEO on January 1, 2026, with Marcos Galperin moving to Executive Chairman
Berkshire Hathaway reported second-quarter 2025 net earnings attributable to shareholders of $12.37 billion, down from $30.35 billion a year earlier, and first-half net earnings of $16.97 billion, down from $43.05 billion. Operating earnings, which exclude investment gains and losses, slipped to $11.16 billion from $11.60 billion, and the company recorded a $3.76 billion other-than-temporary impairment on its Kraft Heinz investment.
Q2 2025 net earnings were $12.37 billion, versus $30.35 billion in Q2 2024.
Q2 2025 operating earnings were $11.16 billion, versus $11.60 billion in Q2 2024.
Q2 2025 included a $3.76 billion other-than-temporary impairment of the Kraft Heinz investment.
Insurance float was approximately $174 billion at June 30, 2025, up $3 billion since year-end 2024.
Terex reported second quarter 2025 results on July 31, 2025, with EPS of $1.49 and sales of $1.5 billion, up 8% year over year. Operating margin fell 310 basis points to 11.0%, and the company maintained its full-year EPS outlook of $4.70 to $5.10 while raising its Environmental Solutions sales outlook. The company also announced a new $150 million share buyback program.
Q2 EPS of $1.49, including a $0.03 benefit from a lower tax rate
Total net sales of $1.5 billion, up 8% year over year; operating margin of 11.0%, down 310 basis points
Full-year 2025 EPS outlook of $4.70 to $5.10 maintained; full-year ES sales outlook raised to up low double digits
New $150 million share buyback authorized; $21 million of stock repurchased in Q2
onsemi reported second quarter 2025 revenue of $1.47 billion, up 2% from the first quarter but down 15% from the year-earlier quarter. GAAP diluted earnings per share were $0.41, a swing from a loss of $1.15 in the first quarter but below $0.78 a year earlier. The company guided third quarter 2025 revenue to $1,465 million to $1,565 million and non-GAAP diluted EPS to $0.54 to $0.64.
Q2 2025 revenue was $1,468.7 million, versus $1,445.7 million in Q1 2025 and $1,735.2 million in Q2 2024.
GAAP diluted EPS was $0.41 and non-GAAP diluted EPS was $0.53, compared with $0.78 and $0.96 in Q2 2024.
Free cash flow was $106.1 million, and the company returned over 100% of year-to-date free cash flow through share repurchases.
Third quarter 2025 outlook: revenue of $1,465 million to $1,565 million and non-GAAP diluted EPS of $0.54 to $0.64.
Krystal Biotech reported second-quarter 2025 product revenue of $96.0 million, up from $70.3 million a year earlier, and net income of $38.3 million, or $1.29 per diluted share, compared with $15.6 million, or $0.53 per diluted share, in the prior-year quarter. The company also reported $820.8 million in cash and investments and issued FY 2025 non-GAAP R&D and SG&A expense guidance of $150.0 million to $175.0 million.
Q2 2025 product revenue, net: $96.0 million vs. $70.3 million in Q2 2024
Q2 2025 net income: $38.3 million ($1.29 per diluted share) vs. $15.6 million ($0.53) a year earlier
Cash, cash equivalents and investments: $820.8 million as of June 30, 2025
FY 2025 non-GAAP R&D and SG&A expense guidance: $150.0 million to $175.0 million
Energizer reported fiscal third-quarter 2025 results for the period ended June 30, 2025, with net sales up 3.4% to $725.3 million and reported diluted EPS of $2.13, compared with a loss of $0.61 a year earlier. The company raised its full-year 2025 adjusted EPS outlook to $3.55 to $3.65, but the filing attributes much of the earnings gain to $112.4 million of production credits, and organic net sales grew only 0.1%.
Net sales were $725.3 million, up 3.4% from $701.4 million; organic net sales rose 0.1%.
Reported diluted EPS was $2.13 versus a loss of $0.61; adjusted EPS was $1.13 versus $0.79, with production credits of $112.4 million recorded in the quarter.
FY2025 adjusted EPS outlook was raised to $3.55 to $3.65; adjusted EBITDA is now expected at $630 to $640 million.
For the fourth quarter, adjusted EPS is expected at $1.05 to $1.15.
SiriusPoint reported second-quarter 2025 net income available to common shareholders of $59.2 million, or $0.50 per diluted share, down from $109.9 million, or $0.57 per diluted share, a year earlier. Its Core combined ratio improved to 89.5% from 93.3%, and Core income rose to $76.3 million from $46.0 million, mainly due to lower catastrophe losses. The board's Audit Committee also approved a $0.50 quarterly dividend per Series B preference share, payable August 29, 2025.
Net income available to common shareholders was $59.2 million, versus $109.9 million in the second quarter of 2024
Core combined ratio was 89.5%, compared with 93.3% a year earlier; Core income was $76.3 million, versus $46.0 million
Core gross premiums written rose 10.4% to $930.1 million for the quarter
Quarterly dividend of $0.50 per Series B preference share, payable August 29, 2025 to holders of record as of August 14, 2025
Loews Corporation reported second-quarter 2025 net income of $391 million, or $1.87 per share, up from $369 million, or $1.67 per share, a year earlier. Gains at Boardwalk Pipelines and the parent company offset a lower contribution from CNA Financial, which took an $81 million after-tax charge tied to legacy mass tort reserves.
Net income attributable to Loews rose to $391 million ($1.87 per share) from $369 million ($1.67 per share) in Q2 2024.
Boardwalk Pipelines net income rose to $88 million from $70 million, and EBITDA rose 14% to $274 million.
CNA Financial net income fell to $274 million from $291 million, reflecting an $81 million after-tax mass tort development charge.
Loews repurchased 2.9 million shares for $251 million in Q2 2025; book value per share rose to $84.42 from $79.49 at December 31, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.